Menu Search
Equities

Hydration Pharmaceuticals Co Ltd

HPC:ASX

Hydration Pharmaceuticals Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (AUD)0.009
  • Today's Change0.00 / 0.00%
  • Shares traded141.00k
  • 1 Year change-76.92%
  • Beta--
Data delayed at least 20 minutes, as of Sep 10 2024 03:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Hydration Pharmaceuticals Co Ltd grew revenues 10.34% from 9.10m to 10.04m while net income improved from a loss of 10.61m to a smaller loss of 8.10m.
Gross margin56.00%
Net profit margin-79.18%
Operating margin-79.18%
Return on assets-117.74%
Return on equity--
Return on investment-251.39%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Hydration Pharmaceuticals Co Ltd fell by 2.85m. Cash Flow from Financing totalled 2.72m or 27.04% of revenues. In addition the company used 5.73m for operations while cash used for investing totalled .
Cash flow per share--
Price/Cash flow per share--
Book value per share-0.0133
Tangible book value per share-0.0133
More ▼

Balance sheet in USDView more

Hydration Pharmaceuticals Co Ltd has a Debt to Total Capital ratio of 242.21%, a lower figure than the previous year's 853.32%.
Current ratio1.53
Quick ratio0.8282
Total debt/total equity--
Total debt/total capital2.42
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.